Commercialization of Genomics Innovation Program
Backs commercialization of Canadian genomics technology innovation through co-investment support.
The Commercialization of Genomics Innovation Program provided $6.2M CAD DIGITAL co-investment against $15M+ total project value. It focused on commercializing Canadian genomics technology innovation. All intake is closed as of May 2026. Program Guide PDFs exist but were not extracted at ingest.
BiotechMedtechAI
Max award—
Realistic median—
Success rate—
Decision time—
No upcoming rounds verified. Cadence: One-off.